Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: A meta-analysis of case-control studies
- PMID: 24353609
- PMCID: PMC3809248
Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: A meta-analysis of case-control studies
Abstract
Objectives: Genetic factors and environmental factors play a role in pathogenesis of esophageal squamous cell carcinoma (ESCC). Previous studies regarding the association of folate intake and Methylenetetrahydrofolate reductase C677T polymorphism with ESCC was conflicting. We conducted a meta-analysis to investigate the association of MTHFR C677T and folate intake with esophageal cancer risk.
Methodology: MEDLINE, EMBASE and the Chinese Biomedical Database were searched in our study. The quality of studies were evaluated by predefined scale, and The association of polymorphisms of MTHFR C677T and folate intake and ESCC risk was estimated by Odds ratio (ORs) with 95% confidence intervals (CIs).
Results: Nineteen studies (4239 cases and 5575 controls) were included for meta-analysis. A significant association was seen between individuals with MTHFR 677 CT [OR(95%)=1.47(1.32-1.63)] and TT [OR(95%)=1.69(1.49-1.91)] genotypes and ESCC risk (p<0.05). Low intake of folate had significantly higher risk of esophageal cancer among individuals with CT/TT genotype [OR(95%)=1.65(1.1-2.49)], while high intake of folate did not find significant high risk of esophageal cancer among individuals with CT/TT genotype [OR(95%)=1.64 (0.82-3.26)].
Conclusions: Our meta-analysis indicated the folate intake and MTHFR 677CT/TT are associated with the risk of ESCC, and folate showed a significant interaction with polymorphism of MTHFR C677T.
Keywords: Esophageal cancer; Folate intake; Meta-analysis; Methylenetetrahydrofolate reductase C677T; Polymorphism.
Figures
Similar articles
-
Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies.Asian Pac J Cancer Prev. 2013;14(1):21-5. doi: 10.7314/apjcp.2013.14.1.21. Asian Pac J Cancer Prev. 2013. PMID: 23534726
-
Meta-analysis of the relationship between the Metholenetetrahydrofolate reductase C677T genetic polymorphism, folate intake and esophageal cancer.Asian Pac J Cancer Prev. 2011;12(1):247-52. Asian Pac J Cancer Prev. 2011. PMID: 21517266
-
Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer.Asian Pac J Cancer Prev. 2011;12(8):2019-23. Asian Pac J Cancer Prev. 2011. PMID: 22292644
-
The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.Arch Gynecol Obstet. 2016 Sep;294(3):579-88. doi: 10.1007/s00404-016-4037-6. Epub 2016 Feb 15. Arch Gynecol Obstet. 2016. PMID: 26879954 Review.
-
Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.J Neurol Sci. 2013 Dec 15;335(1-2):14-21. doi: 10.1016/j.jns.2013.09.006. Epub 2013 Sep 12. J Neurol Sci. 2013. PMID: 24064257 Review.
Cited by
-
Polymorphisms in the MTHFR gene are associated with recurrence risk in lymph node-positive breast cancer patients.Onco Targets Ther. 2016 Sep 9;9:5603-9. doi: 10.2147/OTT.S104890. eCollection 2016. Onco Targets Ther. 2016. PMID: 27672331 Free PMC article.
-
One-Carbon and Polyamine Metabolism as Cancer Therapy Targets.Biomolecules. 2022 Dec 19;12(12):1902. doi: 10.3390/biom12121902. Biomolecules. 2022. PMID: 36551330 Free PMC article. Review.
-
Polymorphisms in the MTHFR gene are associated with breast cancer risk and prognosis in a Chinese population.Tumour Biol. 2015 May;36(5):3757-62. doi: 10.1007/s13277-014-3016-4. Epub 2015 Jan 8. Tumour Biol. 2015. PMID: 25566964
-
Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment.Antioxidants (Basel). 2023 Jul 29;12(8):1520. doi: 10.3390/antiox12081520. Antioxidants (Basel). 2023. PMID: 37627515 Free PMC article. Review.
References
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin. 2007;57(1):43–66. - PubMed
-
- Wang JM, Xu B, Rao JY, Shen HB, Xue HC, Jiang QW. Diet habits, alcohol drinking, tobacco smoking, green tea drinking, and the risk of esophageal squamous cell carcinoma in the Chinese population. Eur J Gastroenterol Hepatol. 2007;19(2):171–176. - PubMed
-
- Morita M, Kumashiro R, Kubo N, Nakashima Y, Yoshida R, Yoshinaga K, et al. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: epidemiology, clinical findings, and prevention. Int J Clin Oncol. 2010;15(2):126–134. - PubMed
-
- Falk GW. Risk factors for esophageal cancer development. Surg Oncol Clin N Am. 2009;18(3):469–485. - PubMed
-
- De Stefani E, Aune D, Boffetta P, Deneo-Pellegrini H, Ronco AL, Acosta G, et al. Salted meat consumption and the risk of cancer: a multisite case-control study in Uruguay. Asian Pac J Cancer Prev. 2009;10(5):853–857. - PubMed
Publication types
LinkOut - more resources
Full Text Sources